U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C11H12N2O2.ClH
Molecular Weight 240.686
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of IDAZOXAN HYDROCHLORIDE

SMILES

Cl.C1CN=C(N1)C2COC3=CC=CC=C3O2

InChI

InChIKey=MYUBYOVCLMEAOH-UHFFFAOYSA-N
InChI=1S/C11H12N2O2.ClH/c1-2-4-9-8(3-1)14-7-10(15-9)11-12-5-6-13-11;/h1-4,10H,5-7H2,(H,12,13);1H

HIDE SMILES / InChI

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C11H12N2O2
Molecular Weight 204.2252
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Idazoxan is an alpha2 receptor antagonist which also shows activity at imidazoline I1 and I2 receptors and modulates the release of dopamine. Idazoxan was in phase II development in the US. Later the development of idazoxan for schizophrenia was discontinued. It was also in clinical trials for cognition disorders in United Kingdom, and was also discontinued. Idazoxan is used in scientific research as a tool for the study of alpha 2-adrenoceptors.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
7.71 null [pIC50]
8.08 null [pIC50]
7.27 null [pIC50]
Conditions
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
179.5 ng × h/mL
0.3 mg/kg single, oral
dose: 0.3 mg/kg
route of administration: Oral
experiment type: SINGLE
co-administered:
IDAZOXAN plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
560.5 ng × h/mL
0.3 mg/kg single, intravenous
dose: 0.3 mg/kg
route of administration: Intravenous
experiment type: SINGLE
co-administered:
IDAZOXAN plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
5.59 h
0.3 mg/kg single, oral
dose: 0.3 mg/kg
route of administration: Oral
experiment type: SINGLE
co-administered:
IDAZOXAN plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
4.2 h
0.3 mg/kg single, intravenous
dose: 0.3 mg/kg
route of administration: Intravenous
experiment type: SINGLE
co-administered:
IDAZOXAN plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
PubMed

PubMed

TitleDatePubMed
Effects of the pesticide amitraz and its metabolite BTS 27271 on insulin and glucagon secretion from the perfused rat pancreas: involvement of alpha2D-adrenergic receptors.
1999 Nov
Effect of alpha-2 adrenoceptor antagonists on colonic function in rats.
2000 Jun
Hypoxic-ischaemic brain damage in immature rats: effects of adrenoceptor modulation.
2001
Co-transmitter function of ATP in central catecholaminergic neurons of the rat.
2001
Modification of norepinephrine and serotonin, but not dopamine, neuron firing by sustained bupropion treatment.
2001 Apr
Alpha2A-adrenoceptor mediated tachypnea in awake goats.
2001 Apr
Agonist trafficking of G(i/o)-mediated alpha(2A)-adrenoceptor responses in HEL 92.1.7 cells.
2001 Apr
Idazoxan and 8-OH-DPAT modify the behavioral effects induced by either NA, or 5-HT, or dual NA/5-HT reuptake inhibition in the rat forced swimming test.
2001 Apr
The noradrenaline-dopamine interaction in the rat medial prefrontal cortex studied by multi-probe microdialysis.
2001 Apr 27
Nitric oxide-independent effects of tempol on sympathetic nerve activity and blood pressure in normotensive rats.
2001 Aug
Differential responses of regional vascular beds to local injection of agmatine in rats.
2001 Dec
In vitro and in vivo impairment of alpha2-adrenergic receptor-dependent antilipolysis by fatty acids in human adipose tissue.
2001 Dec
Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons.
2001 Dec 13
Desensitization of insulin secretory response to imidazolines, tolbutamide, and quinine. II. Electrophysiological and fluorimetric studies.
2001 Dec 15
Desensitization of insulin secretory response to imidazolines, tolbutamide, and quinine. I. Secretory and morphological studies.
2001 Dec 15
Presynaptic alpha2-adrenoceptor-mediated modulation of adenosine 5' triphosphate and noradrenaline corelease: differences in canine mesenteric artery and vein.
2001 Feb
Imidazolines inhibit secretory responses of rat colonic mucosa to calcium-dependent but not cyclic AMP-dependent secretagogues.
2001 Feb
Differential effects of clonidine, dopamine, dobutamine, and dopexamine on basal and acid-stimulated mucosal blood flow in the rat stomach.
2001 Feb
Rabbit alpha2-adrenoceptors: both platelets and adipocytes have alpha2A-pharmacology.
2001 Jul
Differential [(3)H]idazoxan and [(3)H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) binding to imidazoline I(2) receptors in human postmortem frontal cortex.
2001 Jul 6
The alpha 2 adrenoceptor antagonists RX 821002 and yohimbine delay-dependently impair choice accuracy in a delayed non-matching-to-position task in rats.
2001 Jun
Agmatine inhibits carotid sinus baroreflex in anesthetized rats.
2001 Mar
Receptor phosphorylation mediates estradiol reduction of alpha2-adrenoceptor coupling to G protein in the hypothalamus of female rats.
2001 Mar
Inverse agonist activity at the alpha(2A)-adrenergic receptor.
2001 Mar
The differential effects of prenatal stress in rats on the acoustic startle reflex under baseline conditions and in response to anxiogenic drugs.
2001 Mar 1
Posttraining infusion of norepinephrine and corticotropin releasing factor into the bed nucleus of the stria terminalis enhanced retention in an inhibitory avoidance task.
2001 Mar 31
Morphine and clonidine activate different K+ channels on rat amygdala neurons.
2001 Mar 9
Analysis of ligand activation of alpha 2-adrenoceptor subtypes under conditions of equal G alpha protein stoichiometry.
2001 May
Antidepressant drug-induced alterations in neuron-localized tumor necrosis factor-alpha mRNA and alpha(2)-adrenergic receptor sensitivity.
2001 May
Chronic hypoxia alters prejunctional alpha(2)-receptor function in vascular adrenergic nerves of adult and fetal sheep.
2001 Sep
Dopamine inhibits vasopressin action in the rat inner medullary collecting duct via alpha(2)-adrenoceptors.
2001 Sep
Alpha2-adrenoceptor activation increases a cationic conductance and spontaneous GABAergic synaptic activity in dopaminergic neurones of the rat substantia nigra.
2002
Changes of the excitability of rat trigeminal root ganglion neurons evoked by alpha(2)-adrenoreceptors.
2002
Intrathecal clonidine decreases spinal nitric oxide release in a rat model of complete Freund's adjuvant induced inflammatory pain.
2002 Aug
Effect of antisense knock-down of alpha(2a)- and alpha(2c)-adrenoceptors on the antinociceptive action of clonidine on trigeminal nociception in the rat.
2002 Jul
Involvement of imidazoline receptors in the centrally acting muscle-relaxant effects of tizanidine.
2002 Jun 12
Spinal noradrenergic activation mediates allodynia reduction from an allosteric adenosine modulator in a rat model of neuropathic pain.
2002 May
In vivo tonic modulation of the noradrenaline release in the rat cortex by locus coeruleus somatodendritic alpha(2)-adrenoceptors.
2002 May 10
Biochemical and functional characterization of alpha-adrenergic receptors in the rabbit vagina.
2002 Nov 1
Central serotonergic and adrenergic/imidazoline inhibitory mechanisms on sodium and water intake.
2002 Nov 22
RX 821002 as a tool for physiological investigation of alpha(2)-adrenoceptors.
2002 Summer
Central alpha(2) adrenergic receptors and cholinergic-induced salivation in rats.
2003 Jan 30
Patents

Sample Use Guides

Parkinson's disease:single oral doses (10 mg, 20 mg, and 40 mg) of idazoxan
Route of Administration: Oral
Idazoxan (10(-4) mol/L), an alpha 2-adrenergic receptor (alpha 2-AR) and imidazoline receptor (IR) antagonist, abolished the Agm-induced vasorelaxation completely under the condition of CaCl2-induced precontraction in the isolated aortic artery of rats..
Substance Class Chemical
Created
by admin
on Sun Dec 18 01:58:14 UTC 2022
Edited
by admin
on Sun Dec 18 01:58:14 UTC 2022
Record UNII
15394QZS7A
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
IDAZOXAN HYDROCHLORIDE
MI  
Common Name English
1H-IMIDAZOLE, 2-(2,3-DIHYDRO-1,4-BENZODIOXIN-2-YL)-4,5-DIHYDRO-, MONOHYDROCHLORIDE
Systematic Name English
RX-781094
Code English
1H-IMIDAZOLE, 2-(2,3-DIHYDRO-1,4-BENZODIOXIN-2-YL)-4,5-DIHYDRO-, HYDROCHLORIDE (1:1)
Systematic Name English
(±)-IDAZOXAN MONOHYDROCHLORIDE
Common Name English
RX-781094A
Code English
2-(2,3-DIHYDRO-1,4-BENZODIOXIN-2-YL)-4,5-DIHYDRO-1H-IMIDAZOLE HYDROCHLORIDE
Systematic Name English
IDAZOXAN HYDROCHLORIDE [MI]
Common Name English
Code System Code Type Description
CAS
90755-83-2
Created by admin on Sun Dec 18 01:58:15 UTC 2022 , Edited by admin on Sun Dec 18 01:58:15 UTC 2022
SUPERSEDED
PUBCHEM
154494
Created by admin on Sun Dec 18 01:58:15 UTC 2022 , Edited by admin on Sun Dec 18 01:58:15 UTC 2022
PRIMARY
MERCK INDEX
M6198
Created by admin on Sun Dec 18 01:58:15 UTC 2022 , Edited by admin on Sun Dec 18 01:58:15 UTC 2022
PRIMARY Merck Index
CAS
79944-56-2
Created by admin on Sun Dec 18 01:58:15 UTC 2022 , Edited by admin on Sun Dec 18 01:58:15 UTC 2022
PRIMARY
CAS
109518-43-6
Created by admin on Sun Dec 18 01:58:15 UTC 2022 , Edited by admin on Sun Dec 18 01:58:15 UTC 2022
SUPERSEDED
FDA UNII
15394QZS7A
Created by admin on Sun Dec 18 01:58:15 UTC 2022 , Edited by admin on Sun Dec 18 01:58:15 UTC 2022
PRIMARY
EPA CompTox
DTXSID10920189
Created by admin on Sun Dec 18 01:58:15 UTC 2022 , Edited by admin on Sun Dec 18 01:58:15 UTC 2022
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
ENANTIOMER -> RACEMATE
ENANTIOMER -> RACEMATE